Clinical trials
Pathology clinical trials
Below are recruiting pathology clinical trials, each written for real people, not researchers. We’re tracking 291 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06883084Enrolling by invitation
How lymph node changes affect rectal cancer outcomes
This trial looks at how much the lymph nodes respond to chemoradiation before surgery in people with locally advanced rectal cancer. It aims to understand if that response can predict long-term results and guide future treatment choices.
Ages 18–65 - NCT06876714RecruitingPhase 3
Shorter vs Longer HER2 Therapy for Breast Cancer with Complete Response
This trial compares 6 months versus 12 months of HER2-targeted therapy for people with HER2+ breast cancer who had a complete response after chemo and trastuzumab. The goal is to see if a shorter treatment is just as effective.
Phoenix, ArizonaAges 18 years+ - NCT06846736Enrolling by invitation
Predicting ALK cancer treatment outcomes using digital pathology
This study uses a computer to analyze digital images of tumor tissue from people with a certain type of lung cancer (ALK-positive non-small cell lung cancer). It aims to see if the computer can predict how well newer-generation ALK inhibitors work in these patients.
Ramat GanAges 18 years+ - NCT06856525RecruitingPhase 2/Phase 3
MRI scan to study lung health in e-cigarette users
This study tests a new type of MRI scan to see how e-cigarettes affect your lungs. It's for young adults who vape nicotine regularly. The results may help doctors understand vaping-related lung damage.
Durham, North CarolinaAges 18–35 - NCT06830265Recruiting
Comparing a new biopsy needle to the standard one for prostate cancer
This study tests a new, specially designed biopsy needle system against the standard needle system used for prostate biopsies. The researchers will compare how well each system collects tissue samples from men who have suspicious MRI findings, to see if the new needle might give better results.
New York, New YorkAges 18 years+ - NCT06826157Enrolling by invitation
Brain Wave Patterns in Early Memory Loss and Dementia
This study uses an advanced EEG (electroencephalogram) to measure brain wave activity in people with early Alzheimer's, frontotemporal dementia, or Lewy body dementia. It aims to find patterns that could help doctors better understand the disease and predict how it might progress.
Milan, ItalyAges 50–85 - NCT06833502RecruitingPhase 2
Screening for breast cancer spread after chemo and surgery
This trial aims to find out if doing special scans to check for breast cancer spread to organs (not just lymph nodes) is helpful in certain patients. The study looks at people with breast cancer that had already spread to lymph nodes and did not completely go away with chemotherapy and surgery.
Tampa, FloridaAges 18 years+ - NCT06813300Recruiting
Brain signals during deep brain stimulation for thinking or moving tasks
This study looks at how brain signals change during deep brain stimulation (DBS) when you are thinking or moving. It aims to find better ways to see if DBS is working by recording your brain's electrical activity.
GrenobleAges 18 years+ - NCT06241924Recruiting
Brain wave study in Parkinson's and epilepsy
This study looks at brain wave activity in areas that control movement, both in people with Parkinson's disease who already have deep brain stimulation electrodes and in people with epilepsy who are undergoing brain monitoring with stereo-EEG. The goal is to understand how brain signals change during normal movement and in movement problems, which may help improve treatments.
BordeauxAges 18–75 - NCT06779916Recruiting
Placental cell health in pregnancy complications
This study looks at how cells in the placenta handle stress in pregnancies with complications like preeclampsia or poor fetal growth. It aims to understand why some placentas don't work well, which could lead to better treatments.
NîmesAges 18 years+ - NCT06764355RecruitingPhase 2
Chemo, Immunotherapy, and Chemoradiation Before Surgery for Advanced Esophageal Cancer
This trial tests a combination of chemotherapy, immunotherapy, and chemoradiation before surgery for people with advanced esophageal squamous cell carcinoma. The goal is to see if this approach helps shrink the tumor and improve outcomes.
TaipeiAges 18–75 - NCT06754904Recruiting
Skipping lymph node removal for melanoma with good treatment response
This trial tests whether patients with stage 3 melanoma that shrinks significantly after initial immunotherapy can safely avoid having all their lymph nodes surgically removed. Instead, only the main affected node is removed for testing.
Rotterdam, South HollandAges 16 years+ - NCT06755567Recruiting
Testing MRI to predict immunotherapy and chemo results
This trial is studying how MRI images can help predict response to a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. It aims to improve treatment planning for patients with this type of cancer.
Guangzhou, GuangdongAges 18–80 - NCT06755632Recruiting
Hepatic fibrosis or cirrhosis screening trial
This trial screens for liver scarring (fibrosis) or severe scarring (cirrhosis) caused by hepatitis B or C. It aims to find people who may benefit from further care or treatment.
BobignyAges 18 years+ - NCT05829993Recruiting
AI program to spot ECG heart rhythm risk
This study tests an artificial intelligence (computer) tool that looks at your ECG (heart tracing) to help detect abnormal heart electrical patterns and the risk of dangerous rhythm problems. You may be helping clinicians screen for rhythm risk using ECG data.
ParisAges 18 years+ - NCT06748690Recruiting
Comparing biopsy methods for stomach tumors
This trial compares two ways to take a tissue sample from stomach tumors before surgery to see which works better. The results may help doctors choose the best method for patients.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03416959Recruiting
Register study for surgery patients with long-bone bone metastases
This trial collects and follows information about people who had surgery to treat cancer that spread to their long bones (like the femur or humerus) to prevent or fix a broken bone. It may help doctors better understand outcomes after these surgeries and improve future care.
Bologna, BolognaAges Any age - NCT06719414Recruiting
Using a special MRI to predict rectal cancer response to pre-surgery therapy
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
Guangzhou, GuangdongAges Any age - NCT06720844Recruiting
Precocious puberty and related brain conditions study
This study looks at children with central precocious puberty (early puberty that starts in the brain) to see how often it's linked with other developmental issues. It compares how these children develop and respond to treatment.
Bologna, BolgonaAges Up to 18 years - NCT06697808Recruiting
Ultrasound for detecting brain issues in children
This study tests whether a portable ultrasound can safely spot brain problems in children who already need a CT scan or MRI. The goal is to see if ultrasound could be a faster, easier alternative for finding issues in the emergency room or intensive care unit.
Charlotte, North CarolinaAges Up to 18 years - NCT06653985Recruiting
Hip injection plus physical therapy for mild hip problems
This trial tests a combination of a steroid and lubricant injection into the hip joint plus physical therapy to treat mild hip arthritis or related issues like a labral tear. It aims to see if this approach can reduce pain and improve function without surgery.
Hamilton, OntarioAges 40–60 - NCT06631729Recruiting
Interoceptive exposure app for binge eating disorders
This study tests a smartphone app that helps you notice and cope with body signals linked to binge eating. It is for adults with binge eating disorder or bulimia nervosa who want to try a new digital treatment.
Minneapolis, MinnesotaAges 18–64 - NCT06619106Recruiting
Screening tool for minimal hepatic encephalopathy
This study tests a new cognitive tool to quickly and reliably detect minimal hepatic encephalopathy, a subtle brain change that can occur in people with liver disease. If you have a liver condition like fibrosis or cirrhosis and are already scheduled for a full evaluation (neuropsychological tests, MRI, EEG, and blood ammonia), this tool could help simplify future screening.
ParisAges 18–70 - NCT05427708Recruiting
Breathing training to reduce anxiety symptoms
This study tests whether specific respiratory (breathing) training can reduce anxiety symptoms and fear responses. It may help people who have several kinds of anxiety or trauma-related anxiety, especially if they are not on anxiety medicines or only stable on them.
Austin, TexasAges 18 years+
Hear when a new Pathology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pathology?
- Yes. Clin2 currently lists 291 recruiting pathology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pathology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pathology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.